Page last updated: 2024-12-05

4-acetylbenzoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-Acetylbenzoic acid, also known as p-acetylbenzoic acid, is an organic compound with the formula C9H8O3. It is a white solid that is soluble in ethanol, ether, and chloroform. 4-Acetylbenzoic acid is a versatile building block in organic synthesis, and it is used in the production of pharmaceuticals, dyes, and other fine chemicals. It can be synthesized by the Friedel-Crafts acylation of benzene with acetyl chloride. The reaction is catalyzed by a Lewis acid, such as aluminum chloride. 4-Acetylbenzoic acid has been studied for its potential anti-inflammatory and anti-cancer properties. The compound is also a precursor to other useful compounds, such as 4-hydroxybenzoic acid, which is a common food preservative. Research on 4-acetylbenzoic acid focuses on its potential applications in various fields, including medicine, materials science, and agriculture.'

4-acetylbenzoic acid: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11470
CHEMBL ID130010
SCHEMBL ID211540
MeSH IDM0298232

Synonyms (37)

Synonym
AC-18314
EN300-31858
4-acetylbenzoic acid
benzoic acid, 4-acetyl-
586-89-0
nsc16644
nsc-16644
4-acetylbenzoic acid, 98%
A1024
4'-acetophenonecarboxylic acid
CHEMBL130010
4-acetyl-benzoic acid
A20110
acetophenone-4'-carboxylic acid
acetophenone-4-carboxylic acid
AKOS005207115
p-acetylbenzoic acid
einecs 209-588-5
nsc 16644
FT-0600907
AM20061140
AE-562/42531783
SCHEMBL211540
SY012789
mfcd00002561
4-acetylbenzoicacid
4-acetyl benzoic acid
4-(acetyl)benzoic acid
4-acetylbezoic acid
W-105367
4-acetylbenzoci acid
DTXSID30207323
F0001-1531
CS-W001939
GS-3274
4-carboxyacetophenone
Z335574216

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" In vitro cytotoxic activities against cancerous (human chronic myelogenous leukemia, K562 and murine metastatic melanoma, B16F10) and healthy non-cancerous (murine fibroblasts, L929 and murine melanocytes, Melan-A) cells showed that, compared to free ligands, both of the metal complexes are more active as anticancer agents at low concentration in cancerous cell lines, but also possessed toxic effect at comparatively higher concentration towards the non-cancerous cells."( Cytotoxicity and apoptotic activity of novel organobismuth(V) and organoantimony(V) complexes in different cancer cell lines.
Demicheli, C; Dittz, D; Frézard, F; Ishfaq, M; Islam, A; Marzano, IM; Paz Lopes, MT; Perreira-Maia, EC; Rodrigues, BL, 2016
)
0.43

Compound-Compound Interactions

ExcerptReferenceRelevance
"The similarities and differences of essential oil components in Pericarpium Citri Reticulatae Viride (PCRV) and Pericarpium Citri Reticulatae (PCR) were investigated by GC-MS combined with a chemometric method, named alternative moving window factor analysis (AMWFA)."( Comparative analysis of essential oil components in Pericarpium Citri Reticulatae Viride and Pericarpium Citri Reticulatae by GC-MS combined with chemometric resolution method.
Gao, H; Li, H; Liang, Y; Wang, Y; Yi, L; Yuan, D; Zeng, M, 2008
)
0.35

Dosage Studied

ExcerptRelevanceReference
" In a mouse model of influenza, 5 did not protect the mice from weight loss due to the influenza virus when dosed intranasally."( Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.
Babu, YS; Bantia, S; Chand, P; Chu, N; Cole, LB; Kotian, PL; Laver, WG; Montgomery, JA; Pathak, VP; Petty, SL; Shrout, DP; Walsh, DA; Walsh, GM, 1997
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID147482In vitro inhibitory activity against H1N9 strain of Influenza neuraminidase (membrane) at 7 mM concentration1997Journal of medicinal chemistry, Dec-05, Volume: 40, Issue:25
Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.
AID1277424Cytotoxicity against mouse Melan-a cells assessed as cell viability after 72 hrs by MTT assay2016European journal of medicinal chemistry, Feb-15, Volume: 109Cytotoxicity and apoptotic activity of novel organobismuth(V) and organoantimony(V) complexes in different cancer cell lines.
AID1277423Cytotoxicity against mouse L929 cells assessed as cell viability after 72 hrs by MTT assay2016European journal of medicinal chemistry, Feb-15, Volume: 109Cytotoxicity and apoptotic activity of novel organobismuth(V) and organoantimony(V) complexes in different cancer cell lines.
AID1277427Selectivity index, ratio of IC50 for mouse Melan-a cells to IC50 for mouse B16F10 cells2016European journal of medicinal chemistry, Feb-15, Volume: 109Cytotoxicity and apoptotic activity of novel organobismuth(V) and organoantimony(V) complexes in different cancer cell lines.
AID1277430Selectivity index, ratio of IC50 for mouse Melan-a cells to IC50 for human K562 cells2016European journal of medicinal chemistry, Feb-15, Volume: 109Cytotoxicity and apoptotic activity of novel organobismuth(V) and organoantimony(V) complexes in different cancer cell lines.
AID1277429Selectivity index, ratio of IC50 for mouse L929 cells to IC50 for human K562 cells2016European journal of medicinal chemistry, Feb-15, Volume: 109Cytotoxicity and apoptotic activity of novel organobismuth(V) and organoantimony(V) complexes in different cancer cell lines.
AID1605095Inhibition of N-terminal His6-sumo-tagged full length Staphylococcus aureus ClpP expressed in Escherichia coli BL2 (DE3) at 10 uM pre-incubated for 10 mins before Suc-LY-AMC addition and measured after 1 hr by fluorescence based assay relative to control2020Journal of medicinal chemistry, 03-26, Volume: 63, Issue:6
Discovery of Novel Peptidomimetic Boronate ClpP Inhibitors with Noncanonical Enzyme Mechanism as Potent Virulence Blockers
AID1277425Cytotoxicity against mouse B16F10 cells assessed as cell viability after 72 hrs by MTT assay2016European journal of medicinal chemistry, Feb-15, Volume: 109Cytotoxicity and apoptotic activity of novel organobismuth(V) and organoantimony(V) complexes in different cancer cell lines.
AID1277426Selectivity index, ratio of IC50 for mouse L929 cells to IC50 for mouse B16F10 cells2016European journal of medicinal chemistry, Feb-15, Volume: 109Cytotoxicity and apoptotic activity of novel organobismuth(V) and organoantimony(V) complexes in different cancer cell lines.
AID1277428Cytotoxicity against human K562 cells assessed as cell viability after 72 hrs by tryphan blue assay2016European journal of medicinal chemistry, Feb-15, Volume: 109Cytotoxicity and apoptotic activity of novel organobismuth(V) and organoantimony(V) complexes in different cancer cell lines.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's2 (25.00)29.6817
2010's3 (37.50)24.3611
2020's1 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.86

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.86 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index32.00 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.86)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]